Fresenius Medical Care | FME - Assets



Fresenius Medical Care reported EUR31.29B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Akzo Nobel EUR 14.17B 680M Jun/2025
Alcon AG USD 31.39B 379M Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Beiersdorf EUR 12.92B 87M Jun/2025
DaVita Healthcare Partners USD 17.49B 373.93M Jun/2025
Demant DKK 32.64B 190M Jun/2025
E.ON EUR 109.44B 2.86B Jun/2025
Essilor EUR 61.93B 2.34B Jun/2025
Fresenius EUR 41.32B 1.89B Jun/2025
Fresenius Medical Care EUR 31.29B 1.44B Jun/2025
Genmab DKK 6.46B 122M Jun/2025
Getinge SEK 63.92B 4.3B Dec/2024
Givaudan CHF 12.18B 1.05B Jun/2024
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
GN Store Nord DKK 29.49B 451M Jun/2025
GRIFOLS EUR 19.77B 1.21B Jun/2025
Hikma Pharmaceutical USD 5.13B 286M Dec/2024
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 47.35B 2.02B Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Philips EUR 26.38B 788M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
RWE EUR 97.81B 1.69B Jun/2025
Sanofi 124.96B 6.93B Jun/2025
SAP EUR 68.4B 7.23B Jun/2025
Smith & Nephew USD 10.69B 338M Jun/2025